Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
A novel layered double hydroxide (LDH) nanoparticle/thermogel composite drug delivery system (DDS) for sustained release of brimonidine (Bri) has been designed, prepared, and characterized in this study for treatment of severe glaucoma. Brimonidine is first loaded onto LDH (Bri@LDH) nanoparticles, w...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
American Chemical Society
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/73754 |